QumulusAI director Akbari receives 8,681-share award

The restricted stock units vest on October 1, 2027; reported RSU holdings are conditioned on continued service as a director through applicable vesting dates.

Rhea-AI Filing Summary

QumulusAI, Inc. director Dr. Homaira Akbari received an award covering 8,681 common shares through restricted stock units, scheduled to vest on October 1, 2027. Her reported direct holdings after the transaction were 24,302 shares, including shares to be issued upon vesting and settlement; those shares are conditioned on her remaining a director through applicable vesting dates.

Insider Trade Summary

Grant/Award: 8,681 shares

Grant/Award 1 txn

Insider Akbari Dr. Homaira

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	8,681	$0.00	$0.00

Holdings After Transaction: Common Stock — 24,302 shares (Direct)

Footnotes (2)

1. F1. These shares vest on October 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.
2. F2. Includes 24,302 shares to be issued upon vesting and settlement pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates.

Key Figures

Award shares: 8,681 shares Reported direct holdings: 24,302 shares Vesting date: October 1, 2027

3 metrics

Award shares 8,681 shares Restricted stock unit award

Reported direct holdings 24,302 shares After the transaction; includes shares to be issued upon vesting and settlement

Vesting date October 1, 2027 Restricted stock unit award

Key Terms

restricted stock unit award, vesting and settlement, 2026 Equity Incentive Plan

3 terms

restricted stock unit award financial

"pursuant to a restricted stock unit award"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

vesting and settlement financial

"upon vesting and settlement pursuant to restricted stock unit awards"

2026 Equity Incentive Plan financial

"granted under the QumulusAI, Inc. 2026 Equity Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QMLS shares did director Dr. Homaira Akbari receive in the award?

Dr. Homaira Akbari received an award covering 8,681 common shares through restricted stock units. The shares are scheduled to vest on October 1, 2027.

How many QMLS shares did Dr. Homaira Akbari report after the award?

Her reported direct holdings after the transaction were 24,302 shares. This amount includes shares to be issued upon vesting and settlement of restricted stock unit awards, conditioned on her remaining a director through applicable vesting dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 05:36 PM Accepted by SEC EDGAR 10/05/2026 - 05:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Akbari Dr. Homaira

(Last) (First) (Middle)

817 W PEACHTREE STREET NW, SUITE 935

(Street)

ATLANTA GEORGIA 30308

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QumulusAI, Inc. [ QMLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A		8,681(1)	A	$0	24,302(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares vest on October 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.

2. Includes 24,302 shares to be issued upon vesting and settlement pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates.

	/s/ Homaira Akbari	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)